ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,765 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustryFreienbachEffRx Pharmaceuticals SA
EffRx Pharmaceuticals SA Logo
Verified· 2 sourcesTrust Score
Summary

About the company

The core activity of EffRx Pharmaceuticals SA is the development, approval and marketing of medicines for rare and niche diseases in Europe and Switzerland. The company focuses particularly on the late-stage development and market entry of therapeutics for patients with rare diseases such as osteoporosis, adrenal insufficiency, congenital adrenal hyperplasia and Niemann-Pick disease. EffRx works closely with partners to develop and bring new medicines to market, offering accelerated decision-making processes and rapid market entry for its customers.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
✓ Offered6
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

EffRx Pharmaceuticals SA

Binosto®
Binosto® is a once-weekly effervescent or soluble alendronate formulation for the treatment of osteoporosis; marketed and licensed in several markets.
In-licensing
In-licensing of innovative therapies for Switzerland and Europe, focusing on rare diseases, endocrinology and musculoskeletal indications; includes development, commercialization and market access.
Swiss & European Market Entry
Market entry in Switzerland and Europe for innovative and niche medicines; includes planning, commercialization, launch support and flexible partner solutions.
Rare Diseases – Switzerland
Marketing and provision of medicines for rare diseases in Switzerland, including Alkindi®, Lysodren®, Metopiron® and Miglustat Dipharma®.
Musculoskeletal – Switzerland
Marketing of products for the musculoskeletal area in Switzerland, including Dibase®, Binosto® and Testavan® with professional and patient information.
Pipeline Overview
Overview of the company's own and in-licensed product pipeline with Binosto® as well as rare-disease therapies such as Alkindi® and Miglustat Dipharma®.
Trust & reputation

ranQ Trust Score of EffRx Pharmaceuticals SA: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 54% · As of October 2026

Without public customer reviews the score stays capped.

EffRx Pharmaceuticals SA has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
EffRx Pharmaceuticals SA scores 89.3 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.100.012%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.70.07%
EffRx Pharmaceuticals SA scores 85.0 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).85.022%
EffRx Pharmaceuticals SA scores 88.6 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.88.64%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%
Qualifications+0.00

EffRx Pharmaceuticals SA reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 54%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Knowledge

No knowledge articles yet

Once EffRx Pharmaceuticals SA has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

EffRx Pharmaceuticals SA in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank EffRx Pharmaceuticals SA by reviews, experience and specialisations.

Is this your company?

Claim the company profile of EffRx Pharmaceuticals SA to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Wolleraustrasse 41B
8807 Freienbach

At a glance

Legal form
Corporation
UID
CHE-115.242.363
Founded
2009 · 17 years
Last commercial register change
August 4, 2026
Employees
11 to 20
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    CA
    Cantreat AG
    Freienbach
    PP
    Path Pharma GmbH
    Einsiedeln
    PS
    pharma services Oehler GmbH
    Wollerau
    SX
    Saiba X AG
    Pfäffikon Sz
    IA
    IDEOGEN AG
    Hurden
    ST
    Shield TX (Switzerland) AG
    Wollerau
    HA
    HISTIDE AG
    Schindellegi
    IG
    IDEOGEN GROUP GmbH
    Hurden